Clinical Trial Update: Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents [Phase 1]

View source ↗

Summary

This source documents a completed Phase 1 continuation study of lapatinib as monotherapy or in combination with other anti-cancer agents for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neoplasms, Breast | Phase 1 | Status: COMPLETED